866-997-4948(US-Canada Toll Free)

Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018

Published By :

GlobalData

Published Date : Jun 2012

Category :

Surgical Equipment

No. of Pages : 105 Pages


GlobalDatas new report, Infectious Immunology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018 provides key data, information and analysis on the global infectious immunology market. The report provides market landscape, competitive landscape and market trends information on the infectious immunology market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope
  • Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Brazil and Australia.
  • Key segments covered include Hepatitis Viruses, Retroviruses, Bacteriology and Other Virology.
  • Annualized market revenues data from 2004 to 2011 and forecast forward for seven years to 2018. Company shares data for 2011.
  • Qualitative analysis of key market trends, market drivers, and restraints within infectious immunology market. 
  • The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies. 
  • Key players covered include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Qiagen and Gen-Probe Incorporated. 
Reasons to buy
  • Develop business strategies by understanding the trends and developments that are driving the infectious immunology market globally.
  • Design and develop your product development, marketing and sales strategies.
  • Develop market-entry and market expansion strategies.
  • Identify key players best positioned to take advantage of the emerging market opportunities.
  • Exploit in-licensing and out-licensing opportunities by identifying products that are most likely to ensure a robust return.
  • Whats the next big thing in the infectious immunology market landscape? Identify, understand and capitalize.
  • Make more informed business decisions from the insightful and in-depth analysis of the global infectious immunology market and the factors shaping it.
Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 GlobalData Report Guidance

3 Infectious Immunology Overview
3.1 Infectious Immunology: Market Characterization
3.1.1 Bacteriology
3.1.2 Hepatitis Viruses
3.1.3 Other Virology
3.1.4 Retroviruses

4 Infectious Immunology - Global Market Characterization
4.1 Infectious Immunology Market, Global, Revenue ($m), Historic, 2004 - 2011
4.2 Infectious Immunology Market, Global, Revenue ($m), Forecast, 2011 - 2018
4.3 Infectious Immunology Market, Key Trends
4.3.1 New Technological Developments to Change the Infectious Immunology Market Landscape
4.3.2 Use of Companion Diagnostics to Provide a Personalized Healthcare Solution for Infectious Disease Treatment can be a Key Focus Area in Future
4.3.3 Growing Trend of Development of POCT Tests for Infectious Immunology due to Benefits such as Low Cost and Faster Results
4.4 Global Infectious Immunology, Market Dynamics
4.4.1 Market Drivers
4.4.2 Market Restraints

5 Global Infectious Immunology Market: Analysis by Segment
5.1 Bacteriology Market, Global, Revenue ($m), Historic, 2004 - 2011
5.2 Bacteriology Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.3 Bacteriology, Market Dynamics
5.3.1 Market Drivers
5.3.2 Market Restraint
5.4 Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), Historic, 2004 - 2011
5.5 Hepatitis viruses diagnostics Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.6 Hepatitis Viruses Diagnostics, Market Dynamics
5.6.1 Market Drivers
5.6.2 Market Restraint
5.7 Other Virology Market, Global, Revenue ($m), Historic, 2004 - 2011
5.8 Other Virology Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.9 Other Virology, Market Dynamics
5.9.1 Market Drivers
5.9.2 Market Restraint
5.10 Retroviruses Market, Global, Revenue ($m), Historic, 2004 - 2011
5.11 Retroviruses Market, Global, Revenue ($m), Forecast, 2011 - 2018
5.12 Retroviruses, Market Dynamics
5.12.1 Market Driver
5.12.2 Market Restraint

6 Infectious Immunology Market, Analysis by Country, Revenue ($m), 2004 - 2018
6.1 Infectious Immunology Market, the US, Revenue ($m), Historic, 2004 - 2011
6.2 Infectious Immunology Market, the US, Revenue ($m), Forecast, 2011 - 2018
6.3 Infectious Immunology Market, Canada, Revenue ($m), Historic, 2004 -2011
6.4 Infectious Immunology Market, Canada, Revenue ($m), Forecast, 2011 - 2018
6.5 Infectious Immunology Market, the UK, Revenue ($m), Historic, 2004-2011
6.6 Infectious Immunology Market, the UK, Revenue ($m), Forecast, 2011 - 2018
6.7 Infectious Immunology Market, Germany, Revenue ($m), Historic, 2004 - 2011
6.8 Infectious Immunology Market, Germany, Revenue ($m), Forecast, 2011-2018
6.9 Infectious Immunology Market, France, Revenue ($m), Historic, 2004-2011
6.10 Infectious Immunology Market, France, Revenue ($m), Forecast, 2011-2018
6.11 Infectious Immunology Market, Italy, Revenue ($m), Historic, 2004-2011
6.12 Infectious Immunology Market, Italy, Revenue ($m), Forecast, 2011-2018
6.13 Infectious Immunology Market, Spain, Revenue ($m), Historic, 2004-2011
6.14 Infectious Immunology Market, Spain, Revenue ($m), Forecast, 2011-2018
6.15 Infectious Immunology Market, Japan, Revenue ($m), Historic, 2004-2011
6.16 Infectious Immunology Market, Japan, Revenue ($m), Forecast, 2011-2018
6.17 Infectious Immunology Market, China, Revenue ($m), Historic, 2004-2011
6.18 Infectious Immunology Market, China, Revenue ($m), Forecast, 2011-2018
6.19 Infectious Immunology Market, India, Revenue ($m), Historic, 2004-2011
6.20 Infectious Immunology Market, India, Revenue ($m), Forecast, 2011-2018
6.21 Infectious Immunology Market, Australia, Revenue ($m), Historic, 2004-2011
6.22 Infectious Immunology Market, Australia, Revenue ($m), Forecast, 2011-2018
6.23 Infectious Immunology Market, Brazil, Revenue ($m), Historic, 2004-2011
6.24 Infectious Immunology Market, Brazil, Revenue ($m), Forecast, 2011-2018

7 Infectious Immunology Market - Strategic Competitive Assessment
7.1 Infectious Immunology, Market Share Assessment for Others
7.2 Infectious Immunology, Key Market Participants
7.2.1 Abbott Laboratories
7.2.2 F. Hoffmann-La Roche Ltd.
7.2.3 Siemens Healthcare

8 Infectious Immunology - Strategic Pipeline Assessment

9 Infectious Immunology Market - Strategic Deals Analysis
9.1 Infectious Immunology Market, Partnerships, 2010-2012*
9.2 Infectious Immunology Market, Venture Financing Deals, 2010-2012*
9.3 Infectious Immunology Market, Asset Transaction Deals, 2010-2012*
9.4 Infectious Immunology Market, Equity Offering Deals, 2010-2012*
9.5 Infectious Immunology Market, Acquisitions, 2010-2012*
9.6 Infectious Immunology Market, Debt Offering Deals, 2010-2012*
9.7 Infectious Immunology Market, Private Equity Deals, 2010-2012*
9.8 Infectious Immunology Market, Mergers, 2010-2012*
9.9 Infectious Immunology Market, Licensing Agreement, 2010-2012*
9.10 Key Deals
9.10.1 Siemens Healthcare Diagnostics and Illumina Entered into a Collaboration Partnership
9.10.2 XCyton Announces Receipt of $4.5m from Fidelity Capital Advisors to Launch Novel Diagnostic Platform ‘SES’ for Critical Infections
9.10.3 Abbott Enters into Co-Development Agreement with Genetics Lab for Molecular Assay Development
9.10.4 Quanterix, Beth Israel Deaconess and Forsyth Institute Enter into Partnership to Develop a Tuberculosis Test

10 Appendix
10.1 Market Definitions
10.1.1 Infectious Immunology
10.2 Acronyms
10.3 Sources
10.4 Research Methodology
10.4.1 Secondary Research
10.4.2 Primary Research
10.4.3 Models
10.4.4 Forecasts
10.4.5 Expert Panels
10.5 GlobalData Consulting
10.6 Contact Us
10.7 Disclaimer

List of Table


Table 1: List of Viruses which Commonly Infect Humans, by Nucleic Acid and Family* 10
Table 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011 13
Table 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018 14
Table 4: Home Based Testing Market, by Application and Test Type 19
Table 5: Number of Corporate Diagnostic Laboratory Chains, India, 2010 20
Table 6: Bacteriology Market, Global, Revenue ($m), 2004 - 2011 23
Table 7: Bacteriology Market, Global, Revenue ($m), 2011 - 2018 24
Table 8: Bacteriology Market CAGR Comparison, by Country, 2004-2011 27
Table 9: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011 28
Table 10: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018 29
Table 11: Other Virology Market, Global, Revenue ($m), 2004 - 2011 35
Table 12: Other Virology Market, Global, Revenue ($m), 2011 - 2018 36
Table 13: Retroviruses Market, Global, Revenue ($m), 2004 - 2011 39
Table 14: Retroviruses Market, Global, Revenue ($m), 2011 - 2018 40
Table 15: Number of New HIV Infection Cases, the US, 2006-2009 42
Table 16: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011 45
Table 17: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018 46
Table 18: Infectious Immunology Market, Canada, Revenue ($m), 2004-2011 47
Table 19: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018 48
Table 20: Infectious Immunology Market, the UK, Revenue ($m), 2004-2011 49
Table 21: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018 50
Table 22: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011 51
Table 23: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018 52
Table 24: Infectious Immunology Market, France, Revenue ($m), 2004-2011 53
Table 25: Infectious Immunology Market, France, Revenue ($m), 2011-2018 54
Table 26: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011 55
Table 27: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018 56
Table 28: Infectious Immunology Market, Spain, Revenue ($), 2004-2011 57
Table 29: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018 58
Table 30: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011 59
Table 31: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018 60
Table 32: Infectious Immunology Market, China, Revenue ($m), 2004-2011 61
Table 33: Infectious Immunology Market, China, Revenue ($m), 2011-2018 62
Table 34: Infectious Immunology Market, India, Revenue ($m), 2004-2011 63
Table 35: Infectious Immunology Market, India, Revenue ($m), 2011-2018 64
Table 36: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011 65
Table 37: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018 66
Table 38: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011 67
Table 39: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018 68
Table 40: Infectious Immunology Market, Global, Company Share (%), 2011 69
Table 41: Abbott Laboratories, Key Marketed Products*, 2011 71
Table 42: F. Hoffmann-La Roche Ltd., Key Marketed Products*, 2011 74
Table 43: Roche, Infectious Disease Companion Diagnostics Tests, 2011 78
Table 44: Siemens Healthcare, Key Marketed Products*, 2011 80
Table 45: Siemens Healthcare, Emerging Markets Growth, 2008-2010 82
Table 46: Infectious Immunology, Global Pipeline Products, 2011 84
Table 47: Infectious Immunology, Global Pipeline Distribution, by Market Segments, 2011 85
Table 48: Infectious Immunology Market, Deals, 2010-2012* 86
Table 49: Infectious Immunology Market, Partnerships, 2010-2012* 87
Table 50: Infectious Immunology Market, Venture Financing Deals, 2010-2012* 90
Table 51: Infectious Immunology Market, Asset Transaction Deals, 2010-2012* 92
Table 52: Infectious Immunology Market, Equity Offering Deals, 2010-2012* 93
Table 53: Infectious Immunology Market, Acquisitions, 2010-2012* 94
Table 54: Infectious Immunology Market, Debt Offering Deals, 2010-2012* 94
Table 55: Infectious Immunology Market, Private Equity Deals, 2010-2012* 95
Table 56: Infectious Immunology Market, Mergers, 2010-2012* 95
Table 57: Infectious Immunology Market, Licensing Agreement, 2010-2012* 95

List of Chart


Figure 1: Infectious Immunology, Market Segmentation 8
Figure 2: Infectious Immunology Market, Global, Revenue ($m), 2004 - 2011 13
Figure 3: Infectious Immunology Market, Global, Revenue ($m), 2011 - 2018 14
Figure 4: Global Infectious Immunology, Market Dynamics 17
Figure 5: Hub and Spoke Model used by Diagnostic Laboratories 20
Figure 6: Innovation Funnel, Biomarker-based Molecular Diagnostic Product 21
Figure 7: Bacteriology Market, Global, Revenue ($m), 2004 - 2011 23
Figure 8: Bacteriology Market, Global, Revenue ($m), 2011 - 2018 24
Figure 9: Bacteriology Market CAGR Comparison, by Country, 2004-2011 26
Figure 10: Bacteriology Market, Developed* vs. Developing** Countries, Revenue Contribution (%) 27
Figure 11: Hepatitis Viruses Diagnostics Market, Global, Revenue ($m), 2004 - 2011 28
Figure 12: Hepatitis viruses diagnostics Market, Global, Revenue ($m), 2011 - 2018 29
Figure 13: Hepatitis Testing Market Comparison, Developed* vs. Developing** Markets, 2011 30
Figure 14: Estimated New Cases for Hepatitis, the US, 2004-2009 33
Figure 15: Other Virology Market, Global, Revenue ($m), 2004 - 2011 35
Figure 16: Other Virology Market, Global, Revenue ($m), 2011 - 2018 36
Figure 17: Retroviruses Market, Global, Revenue ($m), 2004 - 2011 39
Figure 18: Retroviruses Market, Global, Revenue ($m), 2011 - 2018 40
Figure 19: Number of New HIV Infection Cases, the US, 2006-2009 42
Figure 20: Infectious Immunology Market, the US, Revenue ($m), 2004 - 2011 45
Figure 21: Infectious Immunology Market, the US, Revenue ($m), 2011 - 2018 46
Figure 22: Infectious Immunology Market, Canada, Revenue ($m), 2004 - 2011 47
Figure 23: Infectious Immunology Market, Canada, Revenue ($m), 2011 - 2018 48
Figure 24: Infectious Immunology Market, the UK, Revenue ($m), 2004 - 2011 49
Figure 25: Infectious Immunology Market, the UK, Revenue ($m), 2011 - 2018 50
Figure 26: Infectious Immunology Market, Germany, Revenue ($m), 2004 - 2011 51
Figure 27: Infectious Immunology Market, Germany, Revenue ($m), 2011-2018 52
Figure 28: Infectious Immunology Market, France, Revenue ($m), 2004-2011 53
Figure 29: Infectious Immunology Market, France, Revenue ($m), 2011-2018 54
Figure 30: Infectious Immunology Market, Italy, Revenue ($m), 2004-2011 55
Figure 31: Infectious Immunology Market, Italy, Revenue ($m), 2011-2018 56
Figure 32: Infectious Immunology Market, Spain, Revenue ($m), 2004-2011 57
Figure 33: Infectious Immunology Market, Spain, Revenue ($m), 2011-2018 58
Figure 34: Infectious Immunology Market, Japan, Revenue ($m), 2004-2011 59
Figure 35: Infectious Immunology Market, Japan, Revenue ($m), 2011-2018 60
Figure 36: Infectious Immunology Market, China, Revenue ($m), 2004-2011 61
Figure 37: Infectious Immunology Market, China, Revenue ($m), 2011-2018 62
Figure 38: Infectious Immunology Market, India, Revenue ($m), 2004-2011 63
Figure 39: Infectious Immunology Market, India, Revenue ($m), 2011-2018 64
Figure 40: Infectious Immunology Market, Australia, Revenue ($m), 2004-2011 65
Figure 41: Infectious Immunology Market, Australia, Revenue ($m), 2011-2018 66
Figure 42: Infectious Immunology Market, Brazil, Revenue ($m), 2004-2011 67
Figure 43: Infectious Immunology Market, Brazil, Revenue ($m), 2011-2018 68
Figure 44: Infectious Immunology Market, Global, Company Shares (%), 2011 69
Figure 45: Infectious Immunology, Market Share Assessment for Others 70
Figure 46: Abbott Laboratories, SWOT Analysis 72
Figure 47: F. Hoffmann-La Roche Ltd., SWOT Analysis 76
Figure 48: Roche, Revenue Distribution by Geography, 2011 79
Figure 49: Siemens Healthcare, SWOT Analysis 81
Figure 50: Siemens Healthcare, Revenue Share, by Region, 2010 81
Figure 51: Siemens Healthcare, Emerging Markets Growth, 2008-2010 82
Figure 52: Infectious Immunology, Global Pipeline Products, 2011 84
Figure 53: Infectious Immunology, Global Pipeline Distribution, by Market Segment, 2011 85
Figure 54: Infectious Immunology Market, Deals, 2010-2012* 86

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *